Evidence map›Paper›PMID 39287080›Full record

ArticleActa physiologica (Oxford, England)2025

Enteric glial NLRP3 inflammasome contributes to gut mucosal barrier alterations in a mouse model of diet-induced obesity.

Vanessa D'Antongiovanni, Matteo Fornai, Rocchina Colucci, Anna Nericcio, Laura Benvenuti, Clelia Di Salvo, Cristina Segnani, Clarissa Pierucci, Chiara Ippolito, Zoltan H Nemeth and 4 more

Abstract read
In one paragraph

Article in Acta physiologica (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Enteric nervous system as a therapeutic target in gastrointestinal disorders.World journal of gastrointestinal pharmacology and therapeutics · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Vanessa D'AntongiovanniUnit of Histology and Medical Embryology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Matteo FornaiUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Rocchina ColucciDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Anna NericcioDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Laura BenvenutiUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Clelia Di SalvoUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Cristina SegnaniUnit of Histology and Medical Embryology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Clarissa PierucciUnit of Histology and Medical Embryology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Chiara IppolitoUnit of Histology and Medical Embryology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Zoltan H NemethDepartment of Anesthesiology, Columbia University Irving Medical Center, New York, New York, USA.
György HaskóDepartment of Anesthesiology, Columbia University Irving Medical Center, New York, New York, USA.
Nunzia BernardiniUnit of Histology and Medical Embryology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Luca AntonioliUnit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Carolina PellegriniUnit of Histology and Medical Embryology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.ORCID 0000-0003-2644-5430

Funding

Ministero dell'Istruzione, dell'Università e della RicercaUniversità di Pisa
6 · The paper itself

Abstract

aimIn the present study, we investigated the involvement of NLRP3 inflammasome in the intestinal epithelial barrier (IEB) changes associated with obesity, and its role in the interplay between enteric glia and intestinal epithelial cells (IECs).

methodsWild-type C57BL/6J and NLRP3-KO (

resultsHFD mice showed increased body weight, altered IEB integrity, increased GFAP-positive glial cells, and NLRP3 inflammasome hyperactivation. HFD-NLRP3

conclusionHFD intake elicits mucosal enteric gliotic processes characterized by a hyperactivation of NLRP3/caspase-1/IL-1β signaling pathway, that contributes to further exacerbate the disruption of intestinal mucosal barrier integrity. However, we cannot rule out the contribution of NLRP3 inflammasome activation from other cells, such as immune cells, in IEB alterations associated with obesity. Overall, our results suggest that enteric glial NLRP3 inflammasome might represent an interesting molecular target for the development of novel pharmacological approaches aimed at managing the enteric inflammation and intestinal mucosal dysfunctions associated with obesity.

Indexed as

Diet, High-FatInflammasomesIntestinal MucosaMice, Inbred C57BLMice, KnockoutNeurogliaNLR Family, Pyrin Domain-Containing 3 ProteinObesityAnimalsCoculture TechniquesDisease Models, AnimalMaleMiceInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseenteric gliahigh fat‐dietinflammasomeintestinal epithelial barrierintestinal inflammationmucosal inflammationobesity

Identifiers

PMID39287080
PMCPMC11674374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.